{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:47:58Z","timestamp":1790837278938,"version":"4.1.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1211A"],"award-info":[{"award-number":["01GM1211A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell &amp; Developmental Biology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.semcdb.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T02:41:36Z","timestamp":1450320096000},"page":"115-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Altered FGF signalling in congenital craniofacial and skeletal disorders"],"prefix":"10.1016","volume":"53","author":[{"given":"Shahida","family":"Moosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Wollnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2015.12.005_bib0680","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/PL00006120","article-title":"Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families","volume":"44","author":"Coulier","year":"1997","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0685","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/erc.0.0070165","article-title":"Fibroblast growth factors, their receptors and signaling","volume":"7","author":"Powers","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0690","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","author":"Ornitz","year":"2001","journal-title":"Genome Biol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0695","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1073\/pnas.70.9.2702","article-title":"Pituitary extracts and steroid hormones in the control of 3T3 cell growth","volume":"70","author":"Armelin","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0700","series-title":"Inborn Errors of Development \u2013 The Molecular Basis of Clinical Disorders of Morphogenesis","first-page":"367","article-title":"Molecular and cellular biology of FGF signaling","author":"Givol","year":"2003"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0705","doi-asserted-by":"crossref","first-page":"15482","DOI":"10.1074\/jbc.275.20.15482","article-title":"Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4","volume":"275","author":"Yu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0710","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0715","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0720","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","article-title":"Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor","volume":"64","author":"Yayon","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0725","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1646484","article-title":"Requirement of heparan sulphate for bFGF-mediated fibroblast growth and myoblast differentiation","volume":"252","author":"Rapraeger","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0730","first-page":"240","article-title":"Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells","volume":"12","author":"Ornitz","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0735","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0092-8674(94)90032-9","article-title":"Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation","volume":"79","author":"Spivak-Kroizman","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0740","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1242\/dev.126.17.3715","article-title":"Heparan sulphate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development","volume":"126","author":"Lin","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0745","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0750","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by Klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0755","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of \u03b2Klotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0760","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1096\/fj.08-123992","article-title":"Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model","volume":"23","author":"Nakatani","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0765","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"\u03b2Klotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0770","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(00)81688-8","article-title":"Signaling\u20142000 and beyond","volume":"100","author":"Hunter","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0775","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0780","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mrd.1080390112","article-title":"Heparan sulfate fibroblast growth factor receptor complex: structure\u2013function relationships","volume":"39","author":"McKeehan","year":"1994","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0785","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/bi981758m","article-title":"Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex","volume":"38","author":"Wang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0790","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family: the complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0795","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0800","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","article-title":"Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization","volume":"6","author":"Schlessinger","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0805","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0810","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/6.10.1647","article-title":"Craniosynostosis: genes and mechanisms","volume":"6","author":"Wilkie","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0815","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1469-7580.2001.19910143.x","article-title":"Derivation of the mammalian skull vault","volume":"199","author":"Morriss-Kay","year":"2001","journal-title":"J. Anat."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0820","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1601-0825.2005.01176.x","article-title":"FGF signalling in craniofacial development and developmental disorders","volume":"1282","author":"Nie","year":"2006","journal-title":"Oral Dis."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0825","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i4.20","article-title":"FGF signalling in craniofacial biological control and pathological craniofacial development","volume":"20","author":"Hatch","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0830","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1242\/dev.125.7.1241","article-title":"FGF-BMP-, and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development","volume":"125","author":"Kim","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0835","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0925-4773(99)00278-6","article-title":"Expression patterns of Twist and Fgfr1-2 and -3 in the developing mouse coronal suture suggest a key role for Twist in suture initiation and biogenesis","volume":"91","author":"Johnson","year":"2000","journal-title":"Mech. Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0840","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.965602","article-title":"Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18","volume":"16","author":"Liu","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0845","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1101\/gad.965702","article-title":"FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis","volume":"16","author":"Ohbayashi","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0850","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0925-4773(01)00656-6","article-title":"Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development","volume":"113","author":"Hajihosseini","year":"2002","journal-title":"Mech. Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0855","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215549704500710","article-title":"Differential expression of the fibroblast growth factor (FGFR) multigene family in normal human adult tissues","volume":"45","author":"Hughes","year":"1997","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0860","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00006534-199802000-00052","article-title":"Fibroblast growth factor receptors are expressed in craniosynostotic sutures","volume":"101","author":"Britto","year":"1998","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0865","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","article-title":"Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification","volume":"77","author":"Delezoide","year":"1998","journal-title":"Mech. Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0870","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1242\/dev.126.24.5611","article-title":"Fgfr1 and Fgfr2 have distinct differentiation and proliferation-related roles in the developing mouse skull vault","volume":"126","author":"Iseki","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0875","first-page":"877","article-title":"Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling","volume":"17","author":"Marie","year":"2002","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0880","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1242\/dev.127.9.1845","article-title":"Integration of FGF and TWIST in calvarial bone and suture development","volume":"127","author":"Rice","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0885","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ajmg.1320550422","article-title":"Genetic study of nonsyndromic coronal craniosynostosis","volume":"55","author":"Lajeunie","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0890","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ajmg.a.32208","article-title":"A population-based study of craniosynostosis in metropolitan Atlanta, 1989\u20132003","volume":"146A","author":"Boulet","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0895","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ydbio.2009.01.026","article-title":"Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology","volume":"328","author":"Holmes","year":"2009","journal-title":"Dev. Biol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0900","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0960-9822(95)00102-3","article-title":"Functions of fibroblast growth factors and their receptors","volume":"5","author":"Wilkie","year":"1995","journal-title":"Curr. Biol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0905","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1073\/pnas.93.15.7894","article-title":"Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor (FGFR)2 and FGFR2\/New chimeras","volume":"93","author":"Galvin","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0910","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.95.8.4567","article-title":"Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain","volume":"95","author":"Robertson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0915","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-9525(00)89088-5","article-title":"Fibroblast-growth-factor receptor mutations in human skeletal disorders","volume":"11","author":"Muenke","year":"1995","journal-title":"Trends Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0920","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0925","first-page":"1310","article-title":"De l\u2019acrocephalosyndactylie","volume":"23","author":"Apert","year":"1906","journal-title":"Bull. Mem. Soc. Med. Hop. Paris"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0930","first-page":"397","article-title":"Trapezoidocephaly, midface hypoplasia and cartilage abnormalities with multiple synostoses and skeletal fractures","volume":"XI","author":"Antley","year":"1975","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0935","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K","article-title":"FGFR2 mutation associated with clinical manifestations consistent with Antley\u2013Bixler syndrome","volume":"77","author":"Chun","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0940","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng0295-165","article-title":"Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome","volume":"9","author":"Wilkie","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0945","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.1969.tb13975.x","article-title":"Cutis gyratum, acanthosis nigricans and other congenital anomalies: a new syndrome","volume":"81","author":"Beare","year":"1969","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0950","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0022-3476(78)80371-0","article-title":"Cutis gyratum and acanthosis nigricans associated with other anomalies: a distinctive syndrome","volume":"92","author":"Stevenson","year":"1978","journal-title":"J. Pediatr."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0955","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00000637-198904000-00005","article-title":"Crouzon's syndrome associated with acanthosis nigricans: ramifications for the craniofacial surgeon","volume":"22","author":"Breitbart","year":"1989","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0960","first-page":"545","article-title":"Dysostose cranio-faciale hereditaire","volume":"33","author":"Crouzon","year":"1912","journal-title":"Bull. Mem. Soc. Med. Hop. Paris"},{"key":"10.1016\/j.semcdb.2015.12.005_bib0965","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0994-98","article-title":"Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome","volume":"8","author":"Reardon","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0970","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-3476(76)81050-5","article-title":"Craniosynostosis midfacial hypoplasia, and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred","volume":"88","author":"Jackson","year":"1976","journal-title":"J. Pediatr."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0975","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1194-275","article-title":"Jackson\u2013Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2","volume":"8","author":"Jabs","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0980","first-page":"555","article-title":"A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome","volume":"60","author":"Muenke","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0985","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00447500","article-title":"Dominant erbliche Akrocephalosyndaktylie","volume":"90","author":"Pfeiffer","year":"1964","journal-title":"Z. Kinderheilk."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0990","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1194-269","article-title":"A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome","volume":"8","author":"Muenke","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib0995","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ng0295-173","article-title":"Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes","volume":"9","author":"Rutland","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1000","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/302831","article-title":"Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome","volume":"66","author":"Glaser","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1005","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","article-title":"Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome","volume":"97","author":"Yu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1010","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/ddh235","article-title":"Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggest distinct pathophysiological mechanisms for craniofacial and limb abnormalities","volume":"13","author":"Ibrahimi","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.molcel.2007.06.028","article-title":"A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases","volume":"27","author":"Chen","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.celrep.2013.06.025","article-title":"Cracking the molecular origin of intrinsic tyrosine kinase activity through analysis of pathogenic gain-of-function mutations","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1025","first-page":"369","volume":"19","author":"Johnson","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1030","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1073\/pnas.121183798","article-title":"Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome","volume":"98","author":"Ibrahimi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/ddh011","article-title":"Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity","volume":"13","author":"Ibrahimi","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1086\/338758","article-title":"Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis","volume":"70","author":"Kan","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/hmg\/4.3.323","article-title":"Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome","volume":"4","author":"Schell","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng0295-108","article-title":"FGFR2 mutations in Pfeiffer syndrome","volume":"9","author":"Lajeunie","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajmg.1320450305","article-title":"Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis","volume":"45","author":"Cohen","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ejhg.5201558","article-title":"Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome","volume":"14","author":"Lajeunie","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1096-8628(20000703)93:1<22::AID-AJMG5>3.0.CO;2-U","article-title":"Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature","volume":"93","author":"Roscioli","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.1320440120","article-title":"Beare\u2013Stevenson cutis gyrata syndrome","volume":"44","author":"Hall","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1075","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ng0896-492","article-title":"Fibroblast growth factor receptor 2 mutations in Beare\u2013Stevenson cutis gyrata syndrome","volume":"13","author":"Przylepa","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1080","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ajmg.a.32176","article-title":"Second case of Beare\u2013Stevenson syndrome with an FGFR2 ser372cys mutation","volume":"146A","author":"Fonseca","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1085","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/SCS.0b013e3181ec6afe","article-title":"Spectrum of Antley\u2013Bixler syndrome","volume":"21","author":"McGlaughlin","year":"2010","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1096-8628(19990507)84:1<74::AID-AJMG14>3.0.CO;2-R","article-title":"Let's call it \u2018Crouzonodermoskeletal syndrome\u2019 so we won\u2019t be prisoners of our own conventional terminology","volume":"84","author":"Cohen","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng1295-462","article-title":"Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans","volume":"11","author":"Meyers","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1110","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0021-9258(18)89567-9","article-title":"Purification of cartilage-derived growth factor by heparin affinity chromatography","volume":"260","author":"Sullivan","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1115","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1016\/S0021-9258(17)37121-1","article-title":"Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells","volume":"269","author":"Hurley","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1120","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/endo.140.1.6442","article-title":"Prostaglandins regulate the expression of fibroblast growth factor-2 in bone","volume":"140","author":"Sabbieti","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI8641","article-title":"Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation","volume":"105","author":"Montero","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-0177(199909)216:1<72::AID-DVDY9>3.0.CO;2-9","article-title":"Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene","volume":"216","author":"Colvin","year":"1999","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1135","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1359\/jbmr.1999.14.11.1909","article-title":"Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice","volume":"14","author":"Garofalo","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1140","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0092-8674(01)00284-7","article-title":"Male-to-female sex reversal in mice lacking fibroblast growth factor 9","volume":"104","author":"Colvin","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0925-4773(94)90050-7","article-title":"FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions","volume":"45","author":"Mason","year":"1994","journal-title":"Mech. Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/aja.1002030210","article-title":"Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions","volume":"203","author":"Finch","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0925-4773(99)00034-9","article-title":"Genomic structure, mapping, activity and expression of fibroblast growth factor 17","volume":"83","author":"Xu","year":"1999","journal-title":"Mech. Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1242\/dev.114.1.233","article-title":"Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse","volume":"114","author":"Peters","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1170","doi-asserted-by":"crossref","first-page":"D781","DOI":"10.2741\/A321","article-title":"FGF signaling in skeletal development","volume":"3","author":"Naski","year":"1998","journal-title":"Front. Biosci."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1180","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1185","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1190","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1074\/jbc.M002959200","article-title":"Fibroblast growth factor receptor 3 induces gene expression primarily through Ras-independent signal transduction pathways","volume":"276","author":"Choi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1534-5807(02)00261-7","article-title":"Interaction of FGF Ihh\/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation","volume":"3","author":"Minina","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.0507979103","article-title":"Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1210","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1242\/dev.128.22.4523","article-title":"BMP and Ihh\/PTHrP signalling interact to coordinate chondrocyte proliferation and differentiation","volume":"128","author":"Minina","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1215","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","article-title":"A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation","volume":"161","author":"Dailey","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cytogfr.2005.01.007","article-title":"Mechanisms underlying differential responses to FGF signaling","volume":"16","author":"Dailey","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1225","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1230","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a lys650-to-met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1235","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/7.9.1475","article-title":"Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand","volume":"7","author":"Anderson","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1240","doi-asserted-by":"crossref","first-page":"25049","DOI":"10.1074\/jbc.271.40.25049","article-title":"Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains","volume":"271","author":"Neilson","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1245","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"Bellus","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1250","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations of FGFR3","volume":"56","author":"Bellus","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1255","first-page":"95","article-title":"Hypochondroplasia","volume":"122","author":"Walker","year":"1971","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00019605-199204000-00008","article-title":"Thanatophoric dysplasia of the straight-bone type (type 2)","volume":"1","author":"Norman","year":"1992","journal-title":"Clin. Dysmorphol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1265","first-page":"2519","article-title":"Le nanisme thanatophore","volume":"75","author":"Maroteaux","year":"1967","journal-title":"Presse Med."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1270","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1275","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.str.2013.07.017","article-title":"Structural mimicry of a-loop tyrosine phosphorylation by a pathogenic FGF receptor 3 mutation","volume":"21","author":"Huang","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.semcdb.2015.12.005_bib1280","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ajmg.a.32085","article-title":"Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 lys650met mutation","volume":"146A","author":"Zankl","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01644343","article-title":"Osteoglophonic dwarfism","volume":"10","author":"Beighton","year":"1980","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","volume":"76","author":"White","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajhg.2012.02.005","article-title":"Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling","volume":"90","author":"Merrill","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1300","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1093\/hmg\/ddu282","article-title":"Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription","volume":"23","author":"Neben","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1305","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ng1757","article-title":"Mutations in different components of FGF signaling in LADD syndrome","volume":"38","author":"Rohmann","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1310","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-3476(73)80268-9","article-title":"The lacrimo-auriculo-dento-digital syndrome","volume":"83","author":"Hollister","year":"1973","journal-title":"J. Pediatr."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1315","doi-asserted-by":"crossref","first-page":"19802","DOI":"10.1073\/pnas.0709905104","article-title":"Structural basis for reduced FGFR2 activity in LADD syndrome: implications for FGFR autoinhibition and activation","volume":"104","author":"Lew","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-0004.2006.00597.x","article-title":"LADD syndrome is caused by FGF10 mutations","volume":"69","author":"Milunsky","year":"2006","journal-title":"Clin. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1325","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/508433","article-title":"A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome","volume":"79","author":"Toydemir","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1330","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/humu.22597","article-title":"A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly","volume":"35","author":"Makrythanasis","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1340","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1345","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/humu.20511","article-title":"Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation","volume":"28","author":"Bocciardi","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.semcdb.2015.12.005_bib1350","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"}],"container-title":["Seminars in Cell &amp; Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115300185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115300185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T21:58:27Z","timestamp":1657403907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952115300185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":135,"alternative-id":["S1084952115300185"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.12.005","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered FGF signalling in congenital craniofacial and skeletal disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}